International Clinical Trial: Diagnostic Study of a Combined Strategy Using AI-Assisted Multimodal Targeting and Optimized Systemic Needle Biopsy in Prostate Cancer

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131667) titled 'Diagnostic Study of a Combined Strategy Using AI-Assisted Multimodal Targeting and Optimized Systemic Needle Biopsy in Prostate Cancer' on Sept. 4.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: Peking Union Medical College Hospital

Condition: Elevated PSA, suspected prostate cancer

Intervention: Gold Standard:Histopathological examination of prostate biopsy specimens. The presence of prostate cancer and clinically significant prostate cancer is determined according to the pathological findings and ISUP Grade Group, with clinically significant prostate cancer defin...